|
CA2244744A1
(en)
*
|
1996-02-01 |
1997-08-07 |
University Of Florida |
Lyst1 and lyst2 gene compositions and methods of use
|
|
EP1194542A1
(en)
|
1999-03-02 |
2002-04-10 |
Ludwig Institute For Cancer Research |
Cloning of cdna of mage's 5,8,9 and 11 and their uses in diagnosis of cancer
|
|
JP2003516344A
(ja)
|
1999-12-13 |
2003-05-13 |
エピミューン， インコーポレイテッド |
Ｈｌａクラスｉａ２腫瘍関連抗原ペプチドおよびワクチン組成物
|
|
JP4900884B2
(ja)
|
2000-07-31 |
2012-03-21 |
株式会社グリーンペプタイド |
腫瘍抗原
|
|
CA2481304A1
(en)
|
2002-03-27 |
2003-10-09 |
Patrick Hwu |
Method for treating cancer in humans
|
|
DE10225144A1
(de)
|
2002-05-29 |
2003-12-18 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
DE10225139A1
(de)
|
2002-05-29 |
2004-02-26 |
Immatics Biotechnologies Gmbh |
Verfahren zur Identifizierung von immunreaktiven Peptiden
|
|
DE10313819A1
(de)
|
2003-03-24 |
2004-10-07 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
US7807392B1
(en)
|
2003-09-15 |
2010-10-05 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
WO2005076009A2
(en)
|
2004-01-28 |
2005-08-18 |
Immatics Biotechnologies Gmbh |
Method for identifying and quantifying of tumour-associated peptides
|
|
DE102004026135A1
(de)
|
2004-05-25 |
2006-01-05 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
CN101160524A
(zh)
|
2005-02-24 |
2008-04-09 |
西米尼斯公司 |
用于生物样品分类的组合物和方法
|
|
ES2367643T3
(es)
|
2005-04-26 |
2011-11-07 |
Immatics Biotechnologies Gmbh |
Identificador de un epítopo de linfocitos t presentado por el antígeno hla-a2 y derivado de la proteína del receptor de laminina inmadura del antígeno oncofetal y usos de este.
|
|
SI1806358T1
(sl)
|
2005-09-05 |
2010-06-30 |
Immatics Biotechnologies Gmbh |
S tumorjem povezani peptidi ki se promiskuitetnovežejo na molekule humanega levkocitnega antigena HLA razreda II
|
|
EP1760089B1
(en)
|
2005-09-05 |
2009-08-19 |
Immatics Biotechnologies GmbH |
Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine
|
|
WO2008053573A1
(fr)
|
2006-10-30 |
2008-05-08 |
National University Corporation Hokkaido University |
Remède pour néoplasme malin
|
|
HUE032379T2
(en)
|
2007-07-27 |
2017-09-28 |
Immatics Biotechnologies Gmbh |
Composition of tumour-associated peptides and related anti-cancer vaccine
|
|
CN103864893B
(zh)
|
2007-07-27 |
2017-01-04 |
伊玛提克斯生物技术有限公司 |
免疫疗法的免疫抗原表位
|
|
HRP20150820T1
(xx)
|
2007-07-27 |
2015-09-11 |
Immatics Biotechnologies Gmbh |
Nova imunoterapija protiv neuronskih tumora i tumora mozga
|
|
US8603810B2
(en)
*
|
2008-05-09 |
2013-12-10 |
Agency For Science, Technology And Research |
T-cell having a T-cell receptor that recognizes epitope HBC18-27 of hepatitis B viral core antigen
|
|
ES2532896T5
(es)
|
2008-05-14 |
2018-03-20 |
Immatics Biotechnologies Gmbh |
Péptidos del MHC de clase II novedosos y potentes derivados de survivina y neurocan
|
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
|
EP2337795A2
(en)
|
2008-10-01 |
2011-06-29 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
RS53782B1
(sr)
|
2008-10-01 |
2015-06-30 |
Immatics Biotechnologies Gmbh |
Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera
|
|
GB0917094D0
(en)
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
US20130011496A1
(en)
|
2009-11-25 |
2013-01-10 |
Ludwig Institute For Cancer Research Ltd. |
Cancer testis antigens as biomarkers in non-small cell lung cancer
|
|
WO2011073215A2
(en)
|
2009-12-14 |
2011-06-23 |
Immatics Biotechnologies Gmbh |
Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
|
|
GB201004575D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
|
|
GB201019331D0
(en)
|
2010-03-19 |
2010-12-29 |
Immatics Biotechnologies Gmbh |
Methods for the diagnosis and treatment of cancer based on AVL9
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
US9114100B2
(en)
|
2010-05-17 |
2015-08-25 |
Duke University |
Methods of treatment using ex vivo expansion of cord blood T cells
|
|
GB201009222D0
(en)
|
2010-06-02 |
2010-07-21 |
Immatics Biotechnologies Gmbh |
Improved cancer therapy based on tumour associated antigens derived from cyclin D1
|
|
CN101870725B
(zh)
|
2010-06-29 |
2012-06-27 |
郑州大学 |
Mage-4抗肿瘤ctl表位肽及其应用
|
|
GB201015765D0
(en)
|
2010-09-21 |
2010-10-27 |
Immatics Biotechnologies Gmbh |
Use of myeloid cell biomarkers for the diagnosis of cancer
|
|
GB201021289D0
(en)
|
2010-12-15 |
2011-01-26 |
Immatics Biotechnologies Gmbh |
Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
|
|
CA2821582A1
(en)
|
2010-12-14 |
2012-06-21 |
Immatics Biotechnologies Gmbh |
Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
|
|
AU2012302778B2
(en)
|
2011-08-31 |
2016-11-24 |
Mie University |
Vaccine preparation for cancer treatment
|
|
GB2508414A
(en)
*
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
US9937207B2
(en)
|
2013-03-21 |
2018-04-10 |
Sangamo Therapeutics, Inc. |
Targeted disruption of T cell receptor genes using talens
|
|
TWI636065B
(zh)
|
2013-08-05 |
2018-09-21 |
伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物
|
|
PE20150600A1
(es)
|
2013-10-15 |
2015-06-03 |
Vignolo Carlos Alberto Ibanez |
CICLO - BICICLETA HIBRIDA MOTORIZADA 2 x 2
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
WO2015172843A1
(en)
|
2014-05-16 |
2015-11-19 |
Biontech Diagnostics Gmbh |
Methods and kits for the diagnosis of cancer
|
|
GB201411037D0
(en)
|
2014-06-20 |
2014-08-06 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
|
|
GB2528124A
(en)
|
2014-07-11 |
2016-01-13 |
Nec Corp |
Communication system
|
|
JP6599450B2
(ja)
|
2014-10-02 |
2019-10-30 |
アメリカ合衆国 |
がん特異的突然変異に対し抗原特異性を有するｔ細胞を単離する方法
|
|
TWI617841B
(zh)
|
2014-10-22 |
2018-03-11 |
英特爾股份有限公司 |
用於光學系統的防雲紋圖樣擴散器
|
|
WO2016064317A1
(en)
|
2014-10-24 |
2016-04-28 |
Telefonaktiebolaget L M Ericsson (Publ) |
Method and arrangement for csi-rs transmission
|
|
CN104460328B
(zh)
|
2014-10-29 |
2019-05-10 |
小米科技有限责任公司 |
基于设定场景模式的智能设备控制方法和装置
|
|
DE102014016105A1
(de)
|
2014-10-30 |
2016-05-04 |
Head Technology Gmbh |
Superelastische Schlägersaite
|
|
TWI687511B
(zh)
|
2014-10-30 |
2020-03-11 |
美商艾科詹瑟斯有限公司 |
由混合固體廢棄物形成之固體燃料組合物
|
|
MA40904A
(fr)
|
2014-11-03 |
2017-09-12 |
Hygeia Tech Inc |
Compositions d'ester de phorbol et procédés pour traiter ou réduire la durée d'une cytopénie
|
|
WO2016071343A1
(en)
|
2014-11-03 |
2016-05-12 |
Immures S.R.L. |
T cell receptors
|
|
US10786360B2
(en)
|
2014-11-04 |
2020-09-29 |
Spinal Stabilization Technologies Llc |
Percutaneous implantable nuclear prosthesis
|
|
CN107106297B
(zh)
|
2014-11-17 |
2020-01-21 |
二尖瓣辅助治疗有限公司 |
心脏瓣膜假体
|
|
DE102014223758A1
(de)
|
2014-11-20 |
2016-05-25 |
Windmöller & Hölscher Kg |
Kontaktwalze
|
|
EP3221070B1
(en)
|
2014-11-20 |
2020-06-03 |
ABB Schweiz AG |
Electromagnetic brake system and method of controllong molten metal flow in a metal-making process
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
EP3067366A1
(en)
|
2015-03-13 |
2016-09-14 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
GB201510771D0
(en)
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511191D0
(en)
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201511792D0
(en)
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
|
MY189596A
(en)
|
2015-07-15 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
GB201515321D0
(en)
|
2015-08-28 |
2015-10-14 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
|
|
GB201517538D0
(en)
|
2015-10-05 |
2015-11-18 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
HK1258444A1
(zh)
|
2015-10-09 |
2019-11-15 |
Immatics Biotechnologies Gmbh |
抗wt1/hla特异性抗体
|
|
CN105219714A
(zh)
|
2015-10-20 |
2016-01-06 |
上海隆耀生物科技有限公司 |
一种用于激活肺癌特异性免疫反应的试剂盒
|
|
GB201521746D0
(en)
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201521894D0
(en)
|
2015-12-11 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various cancers
|
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
DE102016123859B3
(de)
|
2016-12-08 |
2018-03-01 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
SG11201911430PA
(en)
|
2017-07-04 |
2020-01-30 |
Curevac Ag |
Novel nucleic acid molecules
|
|
US20210147550A1
(en)
|
2017-08-18 |
2021-05-20 |
Joshua Michael Francis |
Antigen-binding proteins targeting shared antigens
|
|
CN111315769A
(zh)
|
2017-09-06 |
2020-06-19 |
加州理工学院 |
信号传导和抗原呈递双功能受体(sabr)
|
|
US11866731B2
(en)
|
2017-11-10 |
2024-01-09 |
Chineo Medical Technology Co., Ltd |
Modified immune cells and uses thereof
|
|
EP3731876A4
(en)
|
2017-12-28 |
2022-04-06 |
Gritstone bio, Inc. |
ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
|
|
HRP20230007T1
(hr)
|
2018-04-11 |
2023-03-03 |
Enterome S.A. |
Antigenski peptidi, namijenjeni sprječavanju i liječenju raka
|
|
JP2021526365A
(ja)
|
2018-05-18 |
2021-10-07 |
チルドレンズ ナショナル メディカル センターＣｈｉｌｄｒｅｎ’Ｓ Ｎａｔｉｏｎａｌ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ |
改善された標的化ｔ細胞療法
|
|
AU2019275072A1
(en)
|
2018-05-23 |
2021-01-21 |
Seattle Project Corp. |
Shared antigens
|
|
CA3102254A1
(en)
|
2018-06-04 |
2019-12-12 |
Apo-T B.V. |
Methods and means for attracting immune effector cells to tumor cells
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
CA3139011A1
(en)
|
2019-05-08 |
2020-11-12 |
Medigene Immunotherapies Gmbh |
Engineered t cells
|
|
PH12021553152A1
(en)
|
2019-06-18 |
2022-08-15 |
Regeneron Pharma |
Mage-a4 t cell receptors and methods of use thereof
|